Sulfadiazine API Market 2022: Industry Size, Emerging Trends, Growth Insights, Opportunities, and Forecast By 2028
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
This report aims to provide a comprehensive presentation of the global market for Sulfadiazine API study by Market Intellix gives insights concerning the market elements influencing the market, Market scope, Market division, and overlays shadow upon the leading market players featuring the positive cutthroat scene and patterns beating the years.
Global Sulfadiazine API Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Sulfadiazine API Market Sales, 2017-2022, 2023-2028, (Tons)
Global top five Sulfadiazine API companies in 2021 (%)
The global Sulfadiazine API market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Purity Above 99% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Sulfadiazine API include Nanhai Beisha Pharmaceutical, Hunan Xiangyikang Pharmaceutical, China Resources Double-crane Pharmaceutical, Yichang Humanwell Pharmaceutical, Northeast Pharmaceutical Group, Shanghai Liuhetang Biotechnology Xiang Cheng Pharmaceutical, Southwest Synthetic Pharmaceutical, Shanghai Zhongxi Sunve Pharmaceutical and Chongqing Kangle Pharmaceutical and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
The study provides the Sulfadiazine API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Segmental Outline:
Global Sulfadiazine API Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Sulfadiazine API Market Segment Percentages, by Type, 2021 (%)
Purity Above 99%
Purity Below 99%
Global Sulfadiazine API Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Sulfadiazine API Market Segment Percentages, by Application, 2021 (%)
Tablet
Ointment
Others
Global Sulfadiazine API Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Tons)
Global Sulfadiazine API Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Sulfadiazine API revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Sulfadiazine API revenues share in global market, 2021 (%)
Key companies Sulfadiazine API sales in global market, 2017-2022 (Estimated), (Tons)
Key companies Sulfadiazine API sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Nanhai Beisha Pharmaceutical
Hunan Xiangyikang Pharmaceutical
China Resources Double-crane Pharmaceutical
Yichang Humanwell Pharmaceutical
Northeast Pharmaceutical Group
Shanghai Liuhetang Biotechnology Xiang Cheng Pharmaceutical
Southwest Synthetic Pharmaceutical
Shanghai Zhongxi Sunve Pharmaceutical
Chongqing Kangle Pharmaceutical
Adia (Shanghai) Pharma
This Report Addresses:
– Market Intelligence enables effective decision-making
– Market estimates and forecasts from 2022 to 2028
– Growth opportunities and trend analysis
– Segment and regional revenue forecast for market evaluation
– Competitive strategy and analysis of market segments
– List of product innovations to stay on top.
– The impact of COVID-19 and how to survive in these fast-growing markets.
1 Introduction to Research & Analysis Reports
1.1 Sulfadiazine API Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Sulfadiazine API Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Sulfadiazine API Overall Market Size
2.1 Global Sulfadiazine API Market Size: 2021 VS 2028
2.2 Global Sulfadiazine API Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Sulfadiazine API Sales: 2017-2028
3 Company Landscape
3.1 Top Sulfadiazine API Players in Global Market
3.2 Top Global Sulfadiazine API Companies Ranked by Revenue
3.3 Global Sulfadiazine API Revenue by Companies
3.4 Global Sulfadiazine API Sales by Companies
3.5 Global Sulfadiazine API Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Sulfadiazine API Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Sulfadiazine API Product Type
3.8 Tier 1, Tier 2 and Tier 3 Sulfadiazine API Players in Global Market
3.8.1 List of Global Tier 1 Sulfadiazine API Companies
3.8.2 List of Global Tier 2 and Tier 3 Sulfadiazine API Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Sulfadiazine API Market Size Markets, 2021 & 2028
4.1.2 Purity Above 99%
4.1.3 Purity Below 99%
4.2 By Type - Global Sulfadiazine API Revenue & Forecasts
4.2.1 By Type - Global Sulfadiazine API Revenue, 2017-2022
4.2.2 By Type - Global Sulfadiazine API Revenue, 2023-2028
4.2.3 By Type - Global Sulfadiazine API Revenue Market Share, 2017-2028
4.3 By Type - Global Sulfadiazine API Sales & Forecasts
4.3.1 By Type - Global Sulfadiazine API Sales, 2017-2022
4.3.2 By Type - Global Sulfadiazine API Sales, 2023-2028
4.3.3 By Type - Global Sulfadiazine API Sales Market Share, 2017-2028
4.4 By Type - Global Sulfadiazine API Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Sulfadiazine API Market Size, 2021 & 2028
5.1.2 Tablet
5.1.3 Ointment
5.1.4 Others
5.2 By Application - Global Sulfadiazine API Revenue & Forecasts
5.2.1 By Application - Global Sulfadiazine API Revenue, 2017-2022
5.2.2 By Application - Global Sulfadiazine API Revenue, 2023-2028
5.2.3 By Application - Global Sulfadiazine API Revenue Market Share, 2017-2028
5.3 By Application - Global Sulfadiazine API Sales & Forecasts
5.3.1 By Application - Global Sulfadiazine API Sales, 2017-2022
5.3.2 By Application - Global Sulfadiazine API Sales, 2023-2028
5.3.3 By Application - Global Sulfadiazine API Sales Market Share, 2017-2028
5.4 By Application - Global Sulfadiazine API Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Sulfadiazine API Market Size, 2021 & 2028
6.2 By Region - Global Sulfadiazine API Revenue & Forecasts
6.2.1 By Region - Global Sulfadiazine API Revenue, 2017-2022
6.2.2 By Region - Global Sulfadiazine API Revenue, 2023-2028
6.2.3 By Region - Global Sulfadiazine API Revenue Market Share, 2017-2028
6.3 By Region - Global Sulfadiazine API Sales & Forecasts
6.3.1 By Region - Global Sulfadiazine API Sales, 2017-2022
6.3.2 By Region - Global Sulfadiazine API Sales, 2023-2028
6.3.3 By Region - Global Sulfadiazine API Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Sulfadiazine API Revenue, 2017-2028
6.4.2 By Country - North America Sulfadiazine API Sales, 2017-2028
6.4.3 US Sulfadiazine API Market Size, 2017-2028
6.4.4 Canada Sulfadiazine API Market Size, 2017-2028
6.4.5 Mexico Sulfadiazine API Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Sulfadiazine API Revenue, 2017-2028
6.5.2 By Country - Europe Sulfadiazine API Sales, 2017-2028
6.5.3 Germany Sulfadiazine API Market Size, 2017-2028
6.5.4 France Sulfadiazine API Market Size, 2017-2028
6.5.5 U.K. Sulfadiazine API Market Size, 2017-2028
6.5.6 Italy Sulfadiazine API Market Size, 2017-2028
6.5.7 Russia Sulfadiazine API Market Size, 2017-2028
6.5.8 Nordic Countries Sulfadiazine API Market Size, 2017-2028
6.5.9 Benelux Sulfadiazine API Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Sulfadiazine API Revenue, 2017-2028
6.6.2 By Region - Asia Sulfadiazine API Sales, 2017-2028
6.6.3 China Sulfadiazine API Market Size, 2017-2028
6.6.4 Japan Sulfadiazine API Market Size, 2017-2028
6.6.5 South Korea Sulfadiazine API Market Size, 2017-2028
6.6.6 Southeast Asia Sulfadiazine API Market Size, 2017-2028
6.6.7 India Sulfadiazine API Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Sulfadiazine API Revenue, 2017-2028
6.7.2 By Country - South America Sulfadiazine API Sales, 2017-2028
6.7.3 Brazil Sulfadiazine API Market Size, 2017-2028
6.7.4 Argentina Sulfadiazine API Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Sulfadiazine API Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Sulfadiazine API Sales, 2017-2028
6.8.3 Turkey Sulfadiazine API Market Size, 2017-2028
6.8.4 Israel Sulfadiazine API Market Size, 2017-2028
6.8.5 Saudi Arabia Sulfadiazine API Market Size, 2017-2028
6.8.6 UAE Sulfadiazine API Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Nanhai Beisha Pharmaceutical
7.1.1 Nanhai Beisha Pharmaceutical Corporate Summary
7.1.2 Nanhai Beisha Pharmaceutical Business Overview
7.1.3 Nanhai Beisha Pharmaceutical Sulfadiazine API Major Product Offerings
7.1.4 Nanhai Beisha Pharmaceutical Sulfadiazine API Sales and Revenue in Global (2017-2022)
7.1.5 Nanhai Beisha Pharmaceutical Key News
7.2 Hunan Xiangyikang Pharmaceutical
7.2.1 Hunan Xiangyikang Pharmaceutical Corporate Summary
7.2.2 Hunan Xiangyikang Pharmaceutical Business Overview
7.2.3 Hunan Xiangyikang Pharmaceutical Sulfadiazine API Major Product Offerings
7.2.4 Hunan Xiangyikang Pharmaceutical Sulfadiazine API Sales and Revenue in Global (2017-2022)
7.2.5 Hunan Xiangyikang Pharmaceutical Key News
7.3 China Resources Double-crane Pharmaceutical
7.3.1 China Resources Double-crane Pharmaceutical Corporate Summary
7.3.2 China Resources Double-crane Pharmaceutical Business Overview
7.3.3 China Resources Double-crane Pharmaceutical Sulfadiazine API Major Product Offerings
7.3.4 China Resources Double-crane Pharmaceutical Sulfadiazine API Sales and Revenue in Global (2017-2022)
7.3.5 China Resources Double-crane Pharmaceutical Key News
7.4 Yichang Humanwell Pharmaceutical
7.4.1 Yichang Humanwell Pharmaceutical Corporate Summary
7.4.2 Yichang Humanwell Pharmaceutical Business Overview
7.4.3 Yichang Humanwell Pharmaceutical Sulfadiazine API Major Product Offerings
7.4.4 Yichang Humanwell Pharmaceutical Sulfadiazine API Sales and Revenue in Global (2017-2022)
7.4.5 Yichang Humanwell Pharmaceutical Key News
7.5 Northeast Pharmaceutical Group
7.5.1 Northeast Pharmaceutical Group Corporate Summary
7.5.2 Northeast Pharmaceutical Group Business Overview
7.5.3 Northeast Pharmaceutical Group Sulfadiazine API Major Product Offerings
7.5.4 Northeast Pharmaceutical Group Sulfadiazine API Sales and Revenue in Global (2017-2022)
7.5.5 Northeast Pharmaceutical Group Key News
7.6 Shanghai Liuhetang Biotechnology Xiang Cheng Pharmaceutical
7.6.1 Shanghai Liuhetang Biotechnology Xiang Cheng Pharmaceutical Corporate Summary
7.6.2 Shanghai Liuhetang Biotechnology Xiang Cheng Pharmaceutical Business Overview
7.6.3 Shanghai Liuhetang Biotechnology Xiang Cheng Pharmaceutical Sulfadiazine API Major Product Offerings
7.6.4 Shanghai Liuhetang Biotechnology Xiang Cheng Pharmaceutical Sulfadiazine API Sales and Revenue in Global (2017-2022)
7.6.5 Shanghai Liuhetang Biotechnology Xiang Cheng Pharmaceutical Key News
7.7 Southwest Synthetic Pharmaceutical
7.7.1 Southwest Synthetic Pharmaceutical Corporate Summary
7.7.2 Southwest Synthetic Pharmaceutical Business Overview
7.7.3 Southwest Synthetic Pharmaceutical Sulfadiazine API Major Product Offerings
7.7.4 Southwest Synthetic Pharmaceutical Sulfadiazine API Sales and Revenue in Global (2017-2022)
7.7.5 Southwest Synthetic Pharmaceutical Key News
7.8 Shanghai Zhongxi Sunve Pharmaceutical
7.8.1 Shanghai Zhongxi Sunve Pharmaceutical Corporate Summary
7.8.2 Shanghai Zhongxi Sunve Pharmaceutical Business Overview
7.8.3 Shanghai Zhongxi Sunve Pharmaceutical Sulfadiazine API Major Product Offerings
7.8.4 Shanghai Zhongxi Sunve Pharmaceutical Sulfadiazine API Sales and Revenue in Global (2017-2022)
7.8.5 Shanghai Zhongxi Sunve Pharmaceutical Key News
7.9 Chongqing Kangle Pharmaceutical
7.9.1 Chongqing Kangle Pharmaceutical Corporate Summary
7.9.2 Chongqing Kangle Pharmaceutical Business Overview
7.9.3 Chongqing Kangle Pharmaceutical Sulfadiazine API Major Product Offerings
7.9.4 Chongqing Kangle Pharmaceutical Sulfadiazine API Sales and Revenue in Global (2017-2022)
7.9.5 Chongqing Kangle Pharmaceutical Key News
7.10 Adia (Shanghai) Pharma
7.10.1 Adia (Shanghai) Pharma Corporate Summary
7.10.2 Adia (Shanghai) Pharma Business Overview
7.10.3 Adia (Shanghai) Pharma Sulfadiazine API Major Product Offerings
7.10.4 Adia (Shanghai) Pharma Sulfadiazine API Sales and Revenue in Global (2017-2022)
7.10.5 Adia (Shanghai) Pharma Key News
8 Global Sulfadiazine API Production Capacity, Analysis
8.1 Global Sulfadiazine API Production Capacity, 2017-2028
8.2 Sulfadiazine API Production Capacity of Key Manufacturers in Global Market
8.3 Global Sulfadiazine API Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Sulfadiazine API Supply Chain Analysis
10.1 Sulfadiazine API Industry Value Chain
10.2 Sulfadiazine API Upstream Market
10.3 Sulfadiazine API Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Sulfadiazine API Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
Research Methodology:
Sulfadiazine API Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|